DistantNews
Support us
Drug case against Jamaican businessman dropped in Antigua
๐Ÿ‡ฏ๐Ÿ‡ฒ Jamaica /Crime & Justice

Drug case against Jamaican businessman dropped in Antigua

From Jamaica Observer · () English

Summarized and contextualized by DistantNews.

At a glance

News Official statement Outcome reported
  • A drug-related case against Jamaican businessman Francis Young was dismissed in Antigua and Barbuda.
  • Young and Nadeem Brandon Doumith were charged after 62 pounds of cannabis were found in a cargo shipment in May 2025.
  • The dismissal of charges against Young follows a similar recent case, with no explanation provided by the Director of Public Prosecutions.

A drug-related case against Jamaican-born businessman Francis Young has been dismissed in Antigua and Barbuda, with the Office of the Director of Public Prosecutions (DPP) deciding not to proceed. Chief Magistrate Ngaio Emanuel formally discontinued the proceedings, though the DPP offered no explanation for the decision.

Young had been jointly charged with Nadeem Brandon Doumith following the discovery of 62 pounds of cannabis, valued at EC$372,000, hidden in a cargo shipment at Deep Water Harbour on May 9, 2025. The charges they faced included conspiracy to commit drug trafficking, possession of cannabis, and importation of cannabis.

While the charges against Young have been withdrawn, the case against Doumith is ongoing and scheduled to return to court on August 8, 2026. Young has resided in Antigua for the past four years with his family and operates a business that employs local Antiguans.

This marks the second high-profile drug case recently discontinued by the DPP's office. Last week, charges were also dropped against Canadian national Roselynee Crisostomo, accused of possessing 67 pounds of cannabis at VC Bird International Airport. In that instance, medical reasons were cited for the discontinuation.

DistantNews Editorial

Originally published by Jamaica Observer. Summarized and contextualized by our editorial team with added local perspective. Read our editorial standards.